The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The FDA approving a new non-opioid painkiller, meaning it does not carry the risk of addiction.
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...
The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...
The Lay’s potato chips recall for undeclared milk was upgraded to the FDA’s highest risk level. Find out what this means for ...
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...
The FDA just set the highest risk level—class 1—for the recall of Lay's Classic Potato Chips amid concern that they contain ...
More than 6,000 bags of Lay’s Classic Chips have been recalled by the FDA and classified at the highest risk level due to ...
Kennedy, President Donald Trump's pick to run the U.S. Department of Health and Human Services, Senate confirmation hearings are scheduled Wednesday and Thursday, Jan. 29-30.
According to the FDA, If consumers have an allergy or sensitivity to milk, they should not consume the product and discard it ...